Matthew Beasley

Matthew Beasley is a seasoned biochemist and molecular biologist with extensive experience in leadership roles within the biotechnology sector. As Co-Founder of Hula Therapeutics since May 2021, and Chief Scientific Officer at Myrio Tx since January 2010, Matthew has demonstrated a strong commitment to advancing therapeutic innovations. Previously, Matthew served as Chief Scientific Officer at Alchemy Biosciences from September 2006 to January 2010. Matthew holds a Bachelor of Science (Hons) degree in Biochemistry and Molecular Biology from the University of Melbourne, earned between 1993 and 1996.